TABLE 2.
Outcome | Data source/instrument | Baseline a | 10 ± 3 days postsurgery | 1 month ± 7 days postsurgery | 3 month ± 14 days postsurgery | 6 month ± 14 days postsurgery |
---|---|---|---|---|---|---|
Pain intensity | PROMIS pain intensity scale | X | X | X | X | X |
Pain intensity | PROMIS NPRS | X | X | X | X | X |
Daily opioid dose and type of opioid | Average daily MMEs use of opioids since discharge | X | X | |||
Opioid use disorder | PROMIS – Prescription pain medication misuse subscale | X | X | X | ||
Mobility | PROMIS mobility | X | X | X | X | X |
Opioid side effects | Adapted medication side effect survey (SPACE) 44 , 45 | X | X | X | X | X |
Opioid persistence | Custom survey | X | ||||
Well‐being | PROMIS 43/PROMIS Peds37 | X | X | X | X | |
Awareness of genotype results (Intervention arm only) | Custom survey | X |
Abbreviations: MMEs, morphine milligram equivalents; NPRS, Numeric Rating Scale – Pain Intensity; PROMIS, Patient Reported Outcomes Measurement Information Systems.
Baseline surveys are administered within 45 days of surgery.